Nexalin Technology
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1776 Yorktown St Ste 550, Houston, Texas...Phone Number
(832) 260-0222Website
www.nexalin.comRevenue
<$5 MillionStock Symbol
NXLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Nexalin Technology
Nexalin Technology, Inc. is a Houston, Texas-based medical device company listed on Nasdaq under NXL, focused on developing non-invasive neurostimulation products for mental health and neurological conditions. Its proprietary Deep Intracranial Frequency Stimulation technology is designed to stimulate deeper brain structures without drugs. Nexalin’s portfolio includes the Gen-2 SYNC in-clinic device and HALO Clarity at-home headset, targeting conditions such as anxiety, depression, insomnia, Alzheimer’s disease, ADHD, and PTSD.Explore more
Nexalin Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nexalin Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nexalin Technology recently announced quarterly report
Check if Nexalin Technology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nexalin Technology is spiking on competitors!
Click to see if Nexalin Technology had a recent Job posting/layoffs
Product Launch: Get notified when Nexalin Technology launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nexalin Technology
Nexalin Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nexalin Technology has new funding data
Recommended Actions
Reach out to Masked Content who joined Nexalin Technology as Masked Content
Find more new buyers
Compare Similar Companies to Nexalin Technology
Compare insights from companies similar to Nexalin Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nexalin Technology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nexalin Technology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nexalin Technology.
Nexalin Technology financials insights
Gather financial insights about Nexalin Technology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$22K
Nexalin Technology Tech Stack
A closer look at the technologies used by Nexalin Technology
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Management, Intellectual Property, Legal Affairs
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Compliance, Governmental Affairs & Regulation, Regulations
New Hire
Executive Move
Executive Moves, New Hire
Nexalin Technology News & Media
Nexalin Technology Announces Reverse Stock Split
HOUSTON, TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), announces that its board of directors has approved a 1-for-30 reverse stock split of the Company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule. The Company’s stockholders approved future reverse stock splits, their timing, and granted the board of directors authority to determine future exact split ratios.Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin’s recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto Alegre, BrazilNexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of lifeNexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
Study using Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform demonstrated rapid, large-magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nexalin Technology
Sign Up For FreeTo access detailed company insights
Nexalin Technology, Inc. is a Houston, Texas-based medical device company listed on Nasdaq under NXL, focused on developing non-invasive neurostimulation products for mental health and neurological conditions. Its proprietary Deep Intracranial Frequency Stimulation technology is designed to stimulate deeper brain structures without drugs. Nexalin’s... Read More
